GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,351 Cr | ₹1,195 Cr | ₹1,635 Cr | ₹2,320 Cr | ₹2,084 Cr |
What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹2,351 Cr |
| Mar2025 | ₹1,195 Cr |
| Mar2024 | ₹1,635 Cr |
| Mar2023 | ₹2,320 Cr |
| Mar2022 | ₹2,084 Cr |
How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,351 Cr | 96.71 | |
| Mar2025 | ₹1,195 Cr | -26.89 | |
| Mar2024 | ₹1,635 Cr | -29.53 | |
| Mar2023 | ₹2,320 Cr | 11.32 | |
| Mar2022 | ₹2,084 Cr | - | |
Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹73,170.2 Cr | 8.6% | 13.4% | 31.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 8.6% |
13.4% |
31.5% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses